Venus Remedies Limited Cytarabine Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Cytarabine Export Records India — #9 Exporter, 18 Shipments, $186.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cytarabine

India Pharmaceutical Trade Intelligence

$10.7M175 Suppliers110 CountriesHS 30049049

ExportsIndia → NETHERLANDS13.5%India → BRAZIL12.5%

ImportsAUSTRALIA → India$4.5M BULGARIA → India$34.8K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ALLOGA FRANCE

Venus Remedies Limited — Cytarabine Exporter #9 | $186.7K Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Cytarabine Exporter Profile

Indian Pharmaceutical Exporter · #9 for Cytarabine · $186.7K export value · DGFT Verified

Venus Remedies Limited is the #9 Indian exporter of Cytarabine with $186.7K in export value and 18 verified shipments. Venus Remedies Limited holds a 1.7% market share in Cytarabine exports across 7 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Cytarabine Export Profile: Buyers & Destinations

Venus Remedies Limited Cytarabine export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Cytarabine?

Country	Value	Shipments	Share
TUNISIA	$111.6K	7	59.8%
COLOMBIA	$47.0K	3	25.2%
PHILIPPINES	$17.6K	1	9.4%
VENEZUELA	$4.2K	2	2.2%
KUWAIT	$3.8K

Who Are the Top Buyers of Cytarabine from Venus Remedies Limited?

Buyer	Country	Value	Orders
P C D T PHARMACIE CENTRALE DE	TUNISIA	$45.5K	2
P.C.D.T	TUNISIA	$33.3K	2
P C D T	TUNISIA	$32.7K	2
A.S.A.S	COLOMBIA	$20.7K	1
2 M I	PHILIPPINES	$17.6K	1
ALPHARMA S A S	COLOMBIA	$13.5K	1
A S A S ALPHARMA SASDESCARGUE DIRECTO	COLOMBIA	$12.8K	1
C D R B G	VENEZUELA	$4.2K	2
M O H	KUWAIT	$3.7K	1
P P C P L	ZIMBABWE	$2.5K	1

Venus Remedies Limited supplies Cytarabine to 13 buyers globally. The largest buyer is P C D T PHARMACIE CENTRALE DE (TUNISIA), followed by P.C.D.T (TUNISIA) and P C D T (TUNISIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cytarabine Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
CYRABOL 1000 MG CYTARABINE FOR INJECTION USP 1000 MG	$71.5K	2
CYRABOL 1000 MG CYTARABINE FOR INJECTION USP 1000 MG	$28.6K	1
ALDACIT 500MG CYTARABINE FOR INJECTION USP 500 MG EACH VIAL CONTAINS: CYTARABINEUSP 500 MG	$20.7K	1
CYTAGET 500MG CYTARABINE SOLUTION FOR INJECTION USP 500 MG/5ML	$17.6K	1
CYRABOL 500 MG CYTARABINE FOR INJECTION	$13.5K	1
CYRABOL 500 MG CYTARABINE FOR INJECTIONUSP 500 MG	$12.8K	1
CYRABOL 100 MG CYTARABINE FOR INJECTIONUSP 100 MG	$7.2K	2
CYRABOL 100 MG CYTARABINE FOR INJECTIONUSP 100 MG	$4.2K	1
CYTARABINE FOR INJECTION USP 1000 MG CYRABOL 1.0 GM BATCH NO. X4ACT013A, MFG. DT. 01/2024, EXP. DT. 12/2025	$3.7K	1
CYRABOL 500 MG CYTARABINE LYOPHILIZED POWDER FOR INJECTABLE SOLUTION 500MG	$2.8K	1

Venus Remedies Limited exports 16 distinct Cytarabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYRABOL 1000 MG CYTARABINE FOR INJECTION USP 1000 MG with 2 shipments worth $71.5K.

How Does Venus Remedies Limited Compare to Nearest Cytarabine Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	UNITED BIOTECH PRIVATE LIMITED	$303.8K	116	13	$2.6K
8	MEDORBIS TRADE LLP	$199.1K	10	1	$19.9K
9	VENUS REMEDIES LIMITED ★	$186.7K	18	7	$10.4K
10	NV REMEDIES PRIVATE LIMITED	$181.6K	9	3	$20.2K
11	PLEASANT EXPORTS	$131.9K	10	1	$13.2K

Venus Remedies Limited ranks #9 among 175 Indian Cytarabine exporters. Average shipment value of $10.4K compared to the market average of $56.0K. The closest competitors by value are UNITED BIOTECH PRIVATE LIMITED and MEDORBIS TRADE LLP.

Which Indian Ports Ship Cytarabine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	249	13.6%
SAHAR AIR	242	13.3%
DELHI AIR	159	8.7%
AHEMDABAD AIR ACC (INAMD4)	145	7.9%
DELHI AIR CARGO ACC (INDEL4)	144	7.9%
AHEMDABAD AIR	142	7.8%
MUNDRA SEA (INMUN1)	139	7.6%
MUNDRA SEA	111	6.1%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Cytarabine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cytarabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 18 individual customs records matching Venus Remedies Limited exporting Cytarabine, covering 16 formulations to 7 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 110+ countries, 381+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cytarabine

Cytarabine

Venus Remedies Limited — Cytarabine Exporter Profile

Venus Remedies Limited — Cytarabine Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Cytarabine?

Who Are the Top Buyers of Cytarabine from Venus Remedies Limited?

What Is India's Total Cytarabine Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Cytarabine Exports?

How Does Venus Remedies Limited Compare to Other Indian Cytarabine Exporters?

What Cytarabine Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Cytarabine Exporters?

Which Indian Ports Ship Cytarabine Exports?

What Other Advanced Oncology Products Does Venus Remedies Limited Export?

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Cytarabine Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cytarabine Export Data from Venus Remedies Limited

Cytarabine Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source